Fundraising Fox
/Companies
Sign in

TendoNova

Atlanta, US · Founded 2017 · 3 known investors

Find your way into TendoNova

135 people in our graph share verified history with the TendoNova team — schools, employers, funds. One of them is your warm intro.

Ben Yuunlockedknows Ian Campbell · together at NextInput (overlapped)
×3knows the team · via Arkstone
×2knows the team · via NextInput
×4knows the team · via OnScale
×2knows the team · via Middle Tennessee State University (MTSU)

TendoNova develops microinvasive medical technology, including its Ocelot Nano device, to treat chronic tendon pain in patients. The company targets clinical use for patients with tendon injuries, including athletes.

BiotechHardwareHealthtechMedical Devices

Founders & leadership

ICIan Campbell
Ian CampbellInvestor & Board MemberIan Campbell holds an MS in Aerospace Engineering from Georgia Tech and has co-founded and exited two prior high-tech ventures: NextInput (MEMS and sensor technology, acquired by Qorvo) and OnScale (cloud-based engineering simulation, acquired by Ansys). He currently serves as an investor and advisor to multiple deep technology companies.
MS
Mark SamuelsNamed on SEC filing
LM
Louis MaliceNamed on SEC filing
LG
Luka GrujicNamed on SEC filing
SK
Shawna KhouriNamed on SEC filing
BR
Brett RogersNamed on SEC filing

Board

JC
Jeff ClarkBoard director
JS
Jonathan ShawBoard director
PH
Peter HaalandBoard directorGeneral Partner at InnerProduct Partners

Investors · 3

InnerProduct PartnersinferredSan Franciscovia Peter Haaland · board

How we know: board seat on SEC Form D · Not right? Tell us

VentureSouthreportedGreenville

How we know: funding news · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$3.8M disclosed across 7 rounds · 2019–2024

▶$270KraisedAug 2024 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jeff ClarkDirector
  • Jonathan ShawDirector
  • Ian CampbellExecutive Officer, Director
  • Peter HaalandDirector
Offering amount
$400K
Amount sold
$270K
First sale
Jun 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$762KraisedMay 2024 · 6 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jonathan ShawDirector
  • Jeff ClarkDirector
  • Mark SamuelsExecutive Officer, Director
  • Ian CampbellDirector
  • Peter HaalandDirector
Offering amount
$1.1M
Amount sold
$762K
First sale
Feb 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$250KraisedJan 2024 · 10 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Shawna KhouriDirector
  • Mark SamuelsExecutive Officer, Director
  • Jonathan ShawDirector
  • Luka GrujicDirector
  • Peter HaalandDirector
  • Brett RogersDirector
  • Louis MaliceDirector
Offering amount
$500K
Amount sold
$250K
First sale
Nov 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$300KraisedOct 2023 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Luka GrujicDirector
  • Jonathan ShawDirector
  • Peter HaalandDirector
  • Louis MaliceDirector
  • Shawna KhouriDirector
  • Brett RogersDirector
  • Mark SamuelsExecutive Officer, Director
Offering amount
$300K
Amount sold
$300K
First sale
Jul 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$440KraisedDec 2022 · 8 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Luka GrujicDirector
  • Shawna KhouriDirector
  • Jonathan ShawDirector
  • Louis MaliceDirector
  • Peter HaalandDirector
  • Brett RogersDirector
  • Mark SamuelsExecutive Officer, Director
Offering amount
$700K
Amount sold
$440K
First sale
Jul 2022
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$446.3KraisedAug 2022 · 11 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jonathan ShawDirector
  • Shawna KhouriDirector
  • Luka GrujicDirector
  • Brett RogersDirector
  • Louis MaliceDirector
  • Mark SamuelsExecutive Officer, Director
  • Peter HaalandDirector
Offering amount
$2M
Amount sold
$446.3K
First sale
Sep 2021
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.4MraisedFeb 2021 · 13 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Mark SamuelsExecutive Officer
  • Peter HaalandDirector
  • Jonathan ShawExecutive Officer, Director
  • Louis MaliceDirector
  • Luka GrujicDirector
  • Shawna KhouriDirector
  • Brett RogersDirector
Offering amount
$1.5M
Amount sold
$1.4M
Minimum investment
$10K
Proceeds to insiders
$50K
First sale
Apr 2019
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 5

by search overlap
Doximity54 shared keywordsDoximity is the largest verified network of healthcare professionals in the U.S., connecting physicians, PAs, NPs, pharmacists, and medical students across specialties and care settings. The platform provides mobile-first tools for clinical communication, collaboration, and workflow optimization.
Sharecare29 shared keywordsSharecare provides AI-powered health navigation for employers and health plans, connecting employees' health questions to their available benefits and appropriate care options. The platform surfaces relevant wellness programs, chronic condition management, and advocacy services within employees' moment of need.
Practo28 shared keywordsPracto operates an online healthcare platform offering a directory of verified doctors, appointment booking at hospitals and clinics, online consultations across 20+ specialities, subscription health plans, diagnostic test collection, and medicine delivery. It also provides practice management and hospital information management software for clinics and hospitals.
Read the Press Release25 shared keywordsStryker is a medical technology company that develops and manufactures products across areas such as orthopaedics, surgical equipment, neurotechnology, and spine care for hospitals and healthcare providers. It operates globally across the Americas, Europe, Asia-Pacific, and the Middle East.
Zocdoc23 shared keywordsZocdoc runs an online marketplace where US patients find in-network doctors and dentists and book in-person or telehealth appointments.

Companies competing with TendoNova for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

New Rep / Dealer Profile - TendoNova: Relief from Chronic Paintendonova.com · Aug 2024TendoNova Welcomes New Board Members - TendoNova: Relief from Chronic Paintendonova.com · Apr 2024

Frequently asked questions

What does TendoNova do?
TendoNova develops microinvasive medical technology, including its Ocelot Nano device, to treat chronic tendon pain in patients. The company targets clinical use for patients with tendon injuries, including athletes.
Who are TendoNova's investors?
TendoNova's investors include Walnut Venture Associates, InnerProduct Partners, VentureSouth.
How much funding has TendoNova raised?
TendoNova has disclosed $3.8M raised across 7 rounds.
Where is TendoNova headquartered?
TendoNova is headquartered in Atlanta, US.